Abstract
Background
Alzheimer's disease (AD) is a complex neurodegenerative disorder that complicates our understanding of its origins. Identifying AD-specific biomarkers can reveal its mechanisms and foster the development of innovative diagnostics and therapies, aiming to unlock new ways to combat this pervasive condition.
Methods
We analyzed gene expression data using Weighted Gene Co-expression Network Analysis (WGCNA) and machine learning (random forest, lasso regression, and SVM-REF) to differentiate AD patients from controls and explore gene functions.
Results
We identified 641 differentially expressed genes (DEGs) and 22 co-expressed genes, with functional enrichment analysis revealing their involvement in immune responses. Notably, EGR1 emerged as a potential diagnostic and therapeutic target.
Conclusion
In our study, we applied WGCNA, DEGs and diverse machine learning approaches to uncover potential biomarkers linked to Alzheimer's Disease (AD) and ferroptosis. A particular hub gene emerged as a promising candidate for novel diagnostic and therapeutic markers specifically within the context of ferroptosis in AD. This discovery sheds new light on the pathogenesis of AD, potentially facilitating the development of groundbreaking diagnostic and therapeutic techniques.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
